Clinical Trials Directory

Trials / Conditions / AIDS-related Diffuse Mixed Cell Lymphoma

AIDS-related Diffuse Mixed Cell Lymphoma

7 registered clinical trials studyying AIDS-related Diffuse Mixed Cell Lymphoma.

StatusTrialSponsorPhase
CompletedIntravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-
NCT01775475
AIDS Malignancy ConsortiumPhase 2
WithdrawnGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgki
NCT01769911
Fred Hutchinson Cancer CenterN/A
CompletedRO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
NCT01158274
National Cancer Institute (NCI)Phase 1
CompletedSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
National Cancer Institute (NCI)Phase 1
CompletedBryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma
NCT00022555
National Cancer Institute (NCI)Phase 1
CompletedTopotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatmen
NCT00005811
National Cancer Institute (NCI)Phase 2
CompletedFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenola
NCT00112593
Fred Hutchinson Cancer CenterN/A